ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 98.6% of ZYME shares are held by financial institutions. PARALLAX VOLATILITY ADVISERS, L.P. is the top corporate investor, holding 0 shares valued at -. A 0% stake in Zymeworks Inc. is owned by the company. SAMSARA BIOCAPITAL, LLC owns 1.62M shares valued at $12.74M, which translates its holding of 2.44% of the stake in the company.
Among the ZYME insiders holding of 0.09% of the stake in company, ECOR1 CAPITAL, LLC, , holds the largest shares of 15.72M. REDMILE GROUP, LLC, 10 percent owner, is the second largest ZYME insider with ownership of 6.08M shares. LILLY ELI & CO, 10 percent owner, stands third with possession of 2.9M shares of that stake.